Gilead Sciences, Inc. (GIS.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 60.89 |
| Open | 60.70 |
| Bid | 59.97 x 25500 |
| Ask | 60.05 x 20000 |
| Day's range | 59.83 - 60.90 |
| 52-week range | 59.83 - 80.00 |
| Volume | |
| Avg. volume | 1,075 |
| Market cap | 75.286B |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 181.64 |
| EPS (TTM) | 0.33 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.88 (4.73%) |
| Ex-dividend date | 14 Jun 2024 |
| 1y target est | N/A |
Insider Monkey23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
- Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
© 2024 Yahoo. All rights reserved.